American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Viskase Holdings, Inc. (ENZN)

$4.35 -0.84% OTC: ENZN · 15-min delayed

LOMBARD, Illinois
Public · OTC: ENZN

Visit website Follow

$26.0KRevenue · FY2024

-$3.4MNet income

ENZNOTC

About Viskase Holdings, Inc.

VISKASE HOLDINGS INC

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · OTC: ENZN
Headquarters: LOMBARD, Illinois
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: ENZN OTC
SEC CIK: 727510
EIN: 222372868
SIC: 2836 Biological Products, (No Diagnostic Substances)

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Viskase Holdings, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/viskase-holdings-inc/"><img src="https://americancompanies.com/badge/viskase-holdings-inc.svg" alt="Viskase Holdings, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Viskase Holdings, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2024: $26.0K
Net income: -$3.4M
Total assets: $42.8M

Source: SEC EDGAR · updated Jun 7, 2026

OTC: ENZN

$4.35 -0.84%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.50 $8.13

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Viskase Holdings, Inc. (ENZN) Stock Price

Reported a net loss of $3.4M in FY2024.
Trading 46% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Viskase Holdings, Inc..

Write a review

Newsroom

News about Viskase Holdings, Inc.

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger GlobeNewswire Inc. · 2026-01-30 · neutral Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger Benzinga · 2026-01-30 · neutral $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--DHIL, TBN, CEPT, and ENZN Benzinga · 2026-01-29 · negative Enzon and Viskase Announce Amendment to Merger Agreement Benzinga · 2025-10-24 · neutral Enzon and Viskase Announce Amendment to Merger Agreement GlobeNewswire Inc. · 2025-10-24 · neutral Enzon and Viskase Enter into Merger Agreement Benzinga · 2025-06-21 · positive

News & sentiment via Polygon.io

FAQ

Viskase Holdings, Inc.: frequently asked questions

Is Viskase Holdings, Inc. an American company?

Viskase Holdings, Inc. is a US-based company headquartered in Lombard, Illinois, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Viskase Holdings, Inc. headquartered?

Viskase Holdings, Inc. is headquartered in Lombard, Illinois, United States.

Is Viskase Holdings, Inc. publicly traded?

Yes — Viskase Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol ENZN on the OTC.

What does Viskase Holdings, Inc. do?

Viskase Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore